Preclinical Pulmonary Programs

About Medera

Founded in 2021 and based in Cambridge, Massachusetts, Medera is a private, clinical-stage biotech pioneering next-generation therapies for cardiovascular and related diseases. The company's core differentiation lies in its integrated platform combining a proprietary intracoronary delivery methodology with a sophisticated human mini-Heart tissue model for discovery and validation. Led by a team of seasoned experts, Medera is advancing a pipeline that strategically addresses high-burden common diseases and niche rare disorders, aiming to create affordable and deliverable genetic medicines. Its operational address is in Boston, MA.

Therapeutic Areas